PNC Financial Services Group Inc. lessened its holdings in Humana Inc (NYSE:HUM) by 1.5% during the second quarter, HoldingsChannel.com reports. The firm owned 37,384 shares of the insurance provider’s stock after selling 585 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Humana were worth $11,127,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Synovus Financial Corp grew its holdings in Humana by 231.6% in the second quarter. Synovus Financial Corp now owns 1,227 shares of the insurance provider’s stock worth $365,000 after purchasing an additional 857 shares during the period. Boston Advisors LLC grew its holdings in shares of Humana by 27.0% during the second quarter. Boston Advisors LLC now owns 138,043 shares of the insurance provider’s stock valued at $41,086,000 after buying an additional 29,367 shares during the last quarter. Glenview Trust Co grew its holdings in shares of Humana by 7.4% during the first quarter. Glenview Trust Co now owns 35,695 shares of the insurance provider’s stock valued at $9,596,000 after buying an additional 2,456 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Humana during the second quarter valued at approximately $4,290,000. Finally, Victory Capital Management Inc. grew its holdings in shares of Humana by 12.0% during the second quarter. Victory Capital Management Inc. now owns 15,382 shares of the insurance provider’s stock valued at $4,578,000 after buying an additional 1,645 shares during the last quarter. Institutional investors and hedge funds own 93.00% of the company’s stock.
HUM opened at $332.88 on Thursday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43. Humana Inc has a 1-year low of $231.90 and a 1-year high of $336.48. The company has a market capitalization of $45.91 billion, a price-to-earnings ratio of 28.43, a price-to-earnings-growth ratio of 1.66 and a beta of 0.96.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.79 by $0.17. The firm had revenue of $14.26 billion during the quarter, compared to analysts’ expectations of $14.16 billion. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the prior year, the company posted $3.49 earnings per share. equities analysts anticipate that Humana Inc will post 14.18 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.60%. Humana’s dividend payout ratio (DPR) is presently 17.08%.
A number of equities research analysts have recently commented on the stock. Argus increased their price target on shares of Humana to $375.00 and gave the company a “buy” rating in a report on Tuesday. Credit Suisse Group increased their price target on shares of Humana from $350.00 to $370.00 and gave the company an “outperform” rating in a report on Tuesday. Morgan Stanley increased their price target on shares of Humana from $365.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday. Piper Jaffray Companies increased their price objective on shares of Humana from $355.00 to $380.00 and gave the company an “overweight” rating in a research report on Friday, August 24th. Finally, Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, August 8th. Six investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Humana presently has an average rating of “Buy” and an average target price of $330.89.
In other news, insider Timothy Alan Wheatley sold 11,468 shares of the stock in a transaction on Tuesday, June 19th. The shares were sold at an average price of $299.40, for a total value of $3,433,519.20. Following the completion of the sale, the insider now directly owns 3,889 shares of the company’s stock, valued at $1,164,366.60. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Cynthia H. Zipperle sold 1,000 shares of the stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $306.01, for a total transaction of $306,010.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 92,431 shares of company stock valued at $28,602,805. Corporate insiders own 0.60% of the company’s stock.
Humana Inc is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.
Further Reading: Why Dividend Stocks May Be Right for You
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.